myelopeptide 1 has been researched along with Multiple Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boĭko, AN; Demina, TL; Gusev, EI; Popova, NF; Stepanenko, RN | 1 |
| Cheknev, SB; Denisov, LA; Ershov, FI; Latysheva, OL | 1 |
| Borisova, AM; Glazko, AV; Petrov, RV; Simonova, AV; Stepanenko, RN | 1 |
1 trial(s) available for myelopeptide 1 and Multiple Sclerosis
| Article | Year |
|---|---|
[Results of clinico-immunological testing of myelopid in chronic forms of multiple sclerosis].
Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Double-Blind Method; Drug Administration Schedule; Female; Humans; In Vitro Techniques; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Placebos; T-Lymphocytes; T-Lymphocytes, Regulatory | 1992 |
2 other study(ies) available for myelopeptide 1 and Multiple Sclerosis
| Article | Year |
|---|---|
[Interactions of interferon with other immunomodulators in the regulation of human natural killer cell activity].
Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Drug Combinations; Drug Interactions; Enkephalin, Leucine-2-Alanine; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Killer Cells, Natural; Multiple Sclerosis; Oligopeptides; Peptides; Recombinant Proteins; Thymus Extracts | 1992 |
[Efficacy of myelopid in immunodeficiency states].
Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Agammaglobulinemia; B-Lymphocytes; Bronchitis; Chronic Disease; Female; Humans; Immune Tolerance; Leukocyte Count; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Pneumonia; Remission Induction; T-Lymphocytes | 1990 |